Vivos Therapeutics, Inc. (VVOS)
0.7199
+0.01
(+1.47%)
USD |
NASDAQ |
May 06, 16:00
0.7006
-0.02
(-2.68%)
After-Hours: 20:00
Vivos Therapeutics Cash from Investing (Quarterly) : -1.581M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | 0.00 |
| Celldex Therapeutics, Inc. | 55.42M |
| Plus Therapeutics, Inc. | -1.077M |
| Atossa Therapeutics, Inc. | -0.007M |
| Abeona Therapeutics, Inc. | 9.554M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.812M |
| Cash from Financing (Quarterly) | 4.335M |
| Free Cash Flow | -17.60M |
| Free Cash Flow Per Share (Quarterly) | -0.5753 |
| Free Cash Flow to Equity (Quarterly) | -6.347M |
| Free Cash Flow to Firm (Quarterly) | -5.343M |
| Free Cash Flow Yield | -257.9% |